Omeros (OMER) Capital Expenditures Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00% |
| Jun 30, 2025 | -83.75% |
| Mar 31, 2025 | -29.31% |
| Dec 31, 2024 | -77.97% |
| Sep 30, 2024 | -96.97% |
| Jun 30, 2024 | -70.91% |
| Dec 31, 2023 | 807.69% |
| Sep 30, 2023 | 1,200.00% |
| Dec 31, 2022 | -82.43% |
| Sep 30, 2022 | -102.91% |
| Sep 30, 2021 | 41.10% |
| Jun 30, 2021 | -38.89% |
| Mar 31, 2021 | -81.82% |
| Sep 30, 2020 | 87.18% |
| Jun 30, 2020 | 48.45% |
| Mar 31, 2020 | -63.74% |
| Dec 31, 2019 | -82.80% |
| Sep 30, 2019 | -55.68% |
| Jun 30, 2019 | -52.22% |
| Mar 31, 2019 | -0.55% |
| Sep 30, 2018 | 158.82% |
| Jun 30, 2018 | -16.80% |
| Mar 31, 2018 | 154.17% |
| Sep 30, 2017 | -22.73% |
| Jun 30, 2017 | 617.65% |
| Dec 31, 2016 | -9.43% |
| Sep 30, 2016 | -39.73% |
| Jun 30, 2016 | -70.18% |
| Dec 31, 2015 | 231.25% |
| Sep 30, 2015 | 630.00% |
| Jun 30, 2015 | 2,950.00% |
| Dec 31, 2014 | -76.12% |
| Sep 30, 2014 | -79.17% |
| Jun 30, 2014 | -500.00% |
| Mar 31, 2014 | -93.18% |
| Dec 31, 2013 | -83.54% |
| Sep 30, 2013 | -46.67% |
| Jun 30, 2013 | -98.63% |
| Mar 31, 2013 | 22.22% |
| Dec 31, 2012 | 892.68% |
| Sep 30, 2012 | 1,185.71% |
| Jun 30, 2012 | -85.71% |
| Mar 31, 2012 | -89.44% |
| Dec 31, 2011 | -14.58% |
| Sep 30, 2011 | -95.45% |